On October 25, 2022, the US FDA granted accelerated approval to Tecvayli® (teclistamab-cqyv, Janssen Biotech, Inc.) for adult patients with […]
The FDA has approved Sarclisa, together with Kyprolis and dexamethasone (Kd), in order to treat adult patients with the relapsed […]
According to phase-I/IIa findings from the ANCHOR (OP-104) trial that were introduced during the second EMN (European Myeloma Network) Meeting, […]
According to outcomes from an ongoing phase 1 study, a bispecific BCMA (B-cell maturation antigen) x CD3 antibody named Teclistamab […]